InvestorsHub Logo
Followers 45
Posts 3487
Boards Moderated 0
Alias Born 05/26/2011

Re: None

Wednesday, 04/28/2021 12:06:46 PM

Wednesday, April 28, 2021 12:06:46 PM

Post# of 118383
rgbp... I hope we will start getting PRs focused on revenue more than anything else? Maybe revenue will show-up on our 3rd. quarter 10K, but it will just be a starter, with revenues building as the Therapies show some success?

I think quite a few new Therapies are in the developmental stage, with the New mRNA process gaining more popularity than the standard treatment processes! The team is working on new Treatments, as well a Vaccines, but treatments are very difficult to arrive at, as can be said for Vaccines too, IMO?

With the new process completed in the past few years, some Co's are licensing-out the Patent to use the mRNA basic process, even ELI LILLY, one of the more prominent Pharmaceutical Companies, has the right to a RGBP patent being licensed to them!

We have something new and promising, and we were in the forefront of mRNA development and Stem Cell curative treatments! It is important to remember that RGBP/Bio-Matrix focused on the latest methods when they were founded, so RGBP should have some kind of developmental advantage after 10+ years of research? GLTA....